Abstract:Tibetan medicine is traditionally prescribed as crude extracts or mixtures owing to the theoretical basis with cross fertilization from other medical systems like Ayurveda and traditional Chinese medicine. This is challenged to elucidate the action mechanism and material foundation of Tibetan medicine due to lacking a method to confirm the bioactive compounds determining the therapy. This work created a new strategy for screening and evaluating the bioactive compounds against cardiovascular ailments from Choerospondias axillaris . It involved the immobilization of endothelin receptor A (ET A R) by a one-step covalent assay, the screening and identification of the bioactive compounds by ET A R column combined with tandem mass spectrometry, and the evaluation of their drug-like properties by calculating the efficiency indexes using the data collected by frontal analysis and adsorption energy distribution. The immobilized ET A R remained good stability in three weeks in terms of specificity and repeatability. Catechin, pinocembrin, and hyperoside were identified as potential ET A R ligands from Choerospondias axillaris with two types of binding sites on the immobilized receptor. Their association constants on the high and low affinity binding sites were (2.53±0.11)×10 5 and (9.94±0.02)×10 3 M -1 for catechin, (1.01±0.12)×10 6 and (7.40±0.03) ×10 4 for hyperoside, and (2.05±0.04)×10 5 and (2.47±0.09)×10 4 M -1 for pinocembrin, respectively. Owing to the highest association constant, hyperoside presented a surface efficiency index of 7.95, and binding efficiency index of 20.7, and the ligandlipophilicity efficiency of 1.38. These indicated that the three compounds were the main ingredients for the therapy of Choerospondias axillaris , and had potential to become lead compounds for anti-cardiovascular drugs based on drug-ET A R interaction. The immobilized receptor-based strategy is possible to become an alternative for screening and assessing bioactive compounds from Tibetan medicine.

Phenotypic Assessment and Ligand Screening of ETA/ETB Receptors with Label-Free Dynamic Mass Redistribution Assay

Micromechanical measurement of membrane receptor binding for label-free drug discovery.

Systematic Characterization of AT1 Receptor Antagonists with Label-Free Dynamic Mass Redistribution Assays.

Molecular Determinants for Ligand Selectivity of the Cell-Free Synthesized Human Endothelin B Receptor

Label-free Cell Phenotypic Profiling and Pathway Deconvolution of Neurotensin Receptor-1.

Screening and evaluation of the hit compound from a DNA-encoded library derived from natural products based on immobilized endothelin receptor A

Distinct Growth Factor-Induced Dynamic Mass Redistribution (DMR) Profiles for Monitoring Oncogenic Signaling Pathways in Various Cancer Cells

A New Assay Based on Fluorescence Resonance Energy Transfer to Determine the Binding Affinity of Bcl-xLInhibitors

Cell-based phenotypic screening of mast cell degranulation unveils kinetic perturbations of agents targeting phosphorylation

Label-free optical biosensor for ligand-directed functional selectivity acting on beta(2) adrenoceptor in living cells

Establishment and Application of High Throughput Screening Model for H1R Antagonists

A High-Throughput Screening System for G-protein-coupled Receptors Using Β-Lactamase Enzyme Complementation Technology.

Label-Free Dynamic Mass Redistribution Assay To Characterize Holistic Chemokine Receptor Pharmacology in Neutrophils

Label-Free Functional Assays of Chemical Receptors Using A Bioengineered Cell-Based Biosensor with Localized Extracellular Acidification Measurement

A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1

Ligand-induced conformational changes in the β1-Adrenergic Receptor Revealed by Hydrogen-Deuterium Exchange Mass Spectrometry

Label-Free Cell Phenotypic Assays for Assessing Drug Polypharmacology.

Label-free cell signaling pathway deconvolution of Angiotensin type 1 receptor reveals time-resolved G-protein activity and distinct AngII and AngIII\IV responses

Screening potential ligands of endothelin receptor A from Choerospondias axillaris and evaluation of their drug-like properties by affinity chromatographic methods

An Efficient and Label-Free LC-MS/MS Method for Assessing Drug's Activity at Dopamine and Serotonin Transporters Using Transporter-Transfected HEK293T Cells.

Single molecule tracking based drug screening